International Colloquium on Hyperemesis Gravidarum 2019

The ICHG organisations and Stichting ZEHG are proud to present the 3rd International Colloquium on Hyperemesis Gravidarum, ICHG 2019.

Bringing together the world’s leading researchers in hyperemesis gravidarum this two day event, in the heart of Amsterdam will be an excellent opportunity for delegates to hear about the latest research developments and innovative treatments for this complex condition.



ICHG - A Vision for International Collaboration and Patient Inclusion - Caitlin Dean

Keynote: How to develop and change disease definitions - Patrick Bossuyt

Developing an International Definition for HG research - Iris Grooten

Determinants of disease course and severity in HG - Rebecca Painter

Does the placenta and appetite hormone GDF15 cause NVP and HG? - Marlena Fejzo

Genomic studies of severe hyperemesis gravidarum in the UK - Catherine Williamson

GDF15. What is it and why might it be involved in Nausea and Vomiting of Pregnancy? - Stephen O’Rahilly

Core Outcomes for Hyperemesis Research - Larissa Jansen

EMPOWER - Secondary care treatment for severe nausea and vomiting in pregnancy - Cath MacParlin

VOMIT - Validating the effect of Ondansetron and Mirtazapine In Treating Hyperemesis Gravidarum - Anne Ostenfeld

Transdermal clonidine for severe HG - Aldo Maina

What do we need for HELP tool to become an evidence based research tool and implemented in care plans? - Kimber MacGibbon

Gestational week of delivery and onset of labour in women with nausea and vomiting in pregnancy and hyperemesis gravidarum: A population-based cohort of 298,549 women from England using electronic medical records - Laila J Tata

Weight matters! Insufficient early regained weight increase risk of unfavorable outcome in hyperemesis pregnancies. – Jone Trovik

Wernicke's encephalopathy in hyperemesis gravidarum – Erik Oudman

Need of medical care due to hyperemesis gravidarum in different pregnancy outcomes – Miina Nurmi

Severe hyperemesis gravidarum increases rates of termination of pregnancy and suicidal ideation; results from a UK questionnaire completed by >5000 participants – Melanie Nana

Implementing guidelines in Ireland - Brian Cleary

Ketones! - Rebecca Painter

Identification and clinical treatment of NVP and HG across primary and secondary care in England - Laila Tata / Linda Fiaschi

Women's experiences of obtaining treatment for HG and how they access and use Clinical Practice Guidelines.- Margaret O’Hara

Testing a cognitive model to predict posttraumatic stress disorder in women following experiences of Hyperemesis Gravidarum - Helen Penny

The impact of Hyperemesis Gravidarum on mother-child attachment and parenting stress up to two years’ postpartum: a cross-sectional study - Helen Penny

The UK's first counselling practice for women affected by HG: Analysis of clinical goals, tasks and methods - Michelle Nicholson

Nausea and Vomiting of Pregnancy is associated with poor sleep quality - Linda Laitinen

Nausea and vomiting during pregnancy genetics consortium - Lucía Colodro Conde

International Research Network Development Meeting - Summary

James Lind Alliance Priority Setting Partnership for Hyperemsis Gravidarum Research – An internationally agreed list of priorities- Caitlin Dean

Prenatal cannabis exposure and offspring neurodevelopment- Hanan El Marroun

Neonatal outcomes following self-reported cannabis use during pregnancy - Luke Grzeskowiak

European antiemetic regulations (restricting metocloprimide use) increases admission rates due to Hyperemesis Gravidarum - Lone Holst

Contextualizing the Potential Risks of Ondansetron Use in Pregnancy - Krista F Huybrechts,

Breakout session for midwives and other interested healthcare professionals

Improving HG Care - Dutch Speaker - Marjolein Houben

What do Service Users want? - Rebecca Painter

Dietary Information and Support - Marion McBride

Mental Health Information and Support - Michelle Nicholson

Improving HG Care - English Speaker - Ria Clarke

Fringe event for international charity and foundation development

Pregnancy Sickness Support

Stichting ZEHG

Vision, Mission, SWOT and Strategies

Service Development

10th - 11th October 2019

Amsterdam, Netherlands

Dr Rebecca Painter

Gynaecologist and fellow in fetal maternal medicine - University of Amsterdam

Patrick MM Bossuyt

Professor of Clinical Epidemiology

Dept. Clinical Epidemiology, Biostatistics & Bioinformatics

Amsterdam University Medical Centers

Caitlin Dean

Chair of Trustees, Pregnancy Sickness Support

PhD Student, University of Amsterdam

Marlena Fejzo

Professor of Research - UCLA, USC and HER Foundation

Iris Grooten

Registrar in obstetrics and gynaecology and PhD student - University of Amsterdam

Larissa Jansen

Junior doctor in obstetrics and gynaecology Franciscus Gasthuis

Researcher on core outcome set and definition of hyperemesis gravidarum at the University of Amsterdam

Cath Williamson

Professor of Women’s Health and Honorary Consultant in Obstetric Medicine at Guy’s and St Thomas’ and King’s College Hospitals.

Stephen O’Rahilly

Co-Director of the Wellcome Trust-MRC Institute of Metabolic Science (IMS) and Director of the MRC Metabolic Diseases Unit.

Aldo Maina

Internist, Ospedale Sant'Anna, in Torino.

Brian Cleary

Hanan El Marroun

Laila Tata

Associate Professor - University of Nottingham

Cath MacParlin

Anne Ostenfeld

MD, PhD student

Dept. of gynaecology and obstetrics North Zealand Hospital, Denmark

Linda Fiaschi

Senior Research Fellow in eHealth

Helen Penny

BSC(Hons), PhD, DClinPsy.

Charlotte Howden

Kimber Wakefield MacGibbon

Director - HER Foundation

Michelle Nicholson

Counsellor, Hyperemesis Counselling

Lucía Colodro Conde

Postdoctoral researcher at the Psychiatric Genetics laboratory at QIMR Berghofer Medical Research Institute in Brisbane (Australia)

Luke Grzeskowiak

Postdoctoral Research Fellow – Robinson Research Institute, University of Adelaide

Specialist Pharmacist – Women’s and Newborn health at Flinders Medical Centre

Affiliate Senior Research Fellow – South Australian Health and Medical Research Institute

Krista F. Huybrechts, MS, PhD

Associate Professor of Medicine at Harvard Medical School and an epidemiologist in the Division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women’s Hospital.

Margaret O’Hara

Lone Holst